MENLO PARK, Calif.--(BUSINESS WIRE)--SRI International, an independent nonprofit research and development organization, and Blanca Pharmaceuticals, a company discovering and developing antibiotics for serious bacterial infections, today announced they will jointly develop and conduct final preclinical studies of Blanca’s carbacephem antibiotic drug candidates, now in late-stage preclinical development. SRI serves as Blanca’s incubator, providing laboratory services and facilities for many of Blanca’s drug development needs.
